London-based Smith & Nephew plc said its Journey II XR knee implant was commercially released in the U.S. and Japan.
The implant is meant for total knee replacement surgery and is mainly targeted toward patients with arthritis.
Smith & Nephew launches knee implant in US, Japan
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
London-based Smith & Nephew plc said its Journey II XR knee implant was commercially released in the U.S. and Japan.
The implant is meant for total knee replacement surgery and is mainly targeted toward patients with arthritis.